A Study of QY201 Tablet in Subjects With Moderate to Severe Atopic Dermatitis
Clinical trial NCT05525715 · UNKNOWN
Trial details
- NCT number
- NCT05525715
- Sponsor
- E-nitiate Biopharmaceuticals (Hangzhou) Co., Ltd.
- Status
- UNKNOWN
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2022-10-01
- Primary completion
- 2025-12-01
- Enrollment
- 260
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.